Medifast (MED) Misses Q4 EPS by 2c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.48 -1.19%
Revenue Growth %: -24.3%
Financial Fact:
Gross Profit: 52.16M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -24.3%
Financial Fact:
Gross Profit: 52.16M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $2.36, $0.02 worse than the analyst estimate of $2.38. Revenue for the quarter came in at $264.9 million versus the consensus estimate of $244.49 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Labcorp acquires MLM Medical Labs to expand lab network
- After an 18% summer selloff in chip stocks, Citi asks what comes next
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
